References
- Jones R, Harper L, Ballarin J, Blockmans D, Brogan P, Bruchfeld A, et al. A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis: ‘MYCYC’. On behalf of the European Vasculitis Study Group. Presse Med. 2013;42:678–9.
- Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.
- Stone JH, Clinical spectrum of antineutrophil cytoplasmic antibodies. UpToDate, Waltham, MA [cited 2014 May 2]. Available from: http://www.uptodate.com/contents/clinical-spectrum-of-antineutrophil-cytoplasmic-antibodies
- Albarède S, Burg E, Dumont G, Fabien N, Nga Pham B. National external quality assessment in auto-immunity: antineutrophil cytoplasmic antibodies. Ann Biol Clin. 2009;67(4):457–64.
- Hoffman GS, Weyand CM, Langford CA, Goronzy JJ. Inflammatory diseases of blood vessels. 2nd ed. Oxford: Blackwell Publishing Ltd; 2012. p. 460–71.
- Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Pariès J, et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum. 2007;57(8):1473–80.